Clinical trial · Interventional
Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer
A Multi-center, International Study to Compare Use of Narrow Band Imaging (NBI) Versus White Light(WL) During Transurethral Resection of Bladder Tumors (TURB) to Asses Recurrence of Bladder Cancer in Terms of Safety and Efficacy
NCT01180478CI-TRIAL-00032655completedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare the recurrence rate at 1 year following Narrow Band Imaging and trans-urethral resection of bladder tumor with White Light and TURB in patients with non-muscle invasive bladder cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Narrow Band Imaging | Device | — | UNRESOLVED |
| White Light | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Narrow Band Imaging
- description
- Narrow Band Imaging (NBI)
- interventionNames
- Device: Narrow Band Imaging
- type
- OTHER
- label
- White Light Trans Urethral Resection
- description
- White Light Trans Urethral Resection
- interventionNames
- Device: White Light
Primary outcomes (1)
- measure
- Number of Participants With Recurrence and Recurrence Rate at 1 Year Following Narrow Band Imaging and TURB (Arm A) Versus White Light Trans Urethral Resection of Bladder Cancer (TURB) (Arm B) in Patients With Non Muscle Invasive (pTa/T1) Bladder Cancer.
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients scheduled for treatment of primary or recurrent non-muscle invasive bladder cancer * Patients greater than 18 years of age * No tumors in the upper tract (kidneys or ureters) * No previous pelvic radiation Exclusion Criteria: * Gross hematuria at the time of resection making visualization with NBI not possible * Participation in other clinical studies with investigations drugs concurrently or within 30 days. * Pregnancy * Conditions associated with a risk of poor compliance or unwilling to follow up
References
Publications (0)
Data not yet available
No reference posted for this study.